UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Inquiry Search clinical trials

Name
UMIN ID

Recruitment status Completed
Unique ID issued by UMIN UMIN000047888
Receipt No. R000054582
Scientific Title Transcatheter closure of secundum atrial septal defect using Cocoon Septal Occluder:- Immediate and long term results
Date of disclosure of the study information 2022/05/29
Last modified on 2022/06/09

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Transcatheter closure of secundum atrial septal defect using Cocoon Septal Occluder:- Immediate and long term results
Acronym Transcatheter closure of secundum atrial septal defect using Cocoon Septal Occluder:- Immediate and long term results
Scientific Title Transcatheter closure of secundum atrial septal defect using Cocoon Septal Occluder:- Immediate and long term results
Scientific Title:Acronym Transcatheter closure of secundum atrial septal defect using Cocoon Septal Occluder:- Immediate and long term results
Region
Asia(except Japan)

Condition
Condition Atrial septal Defect
Classification by specialty
Cardiology Cardiovascular surgery
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To evaluate feasibility, effectiveness, safety, and long term outcome of transcatheter closure (TCC) of atrial septal defect (ASD) using Cocoon septal occluder.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Efficacy: successful closure of defect without significant shunt (not more than mild) on six months of follow-up.

Saftey: successful deployment without either major peri-procedural complications (death, device embolization, cardiac perforation, pericardial effusion, stroke, infective endocarditis, atrioventricular block) or late embolization, erosion, and residual shunting on follow up.
Key secondary outcomes Death, device embolization, cardiac perforation, pericardial effusion, stroke, infective endocarditis, atrioventricular block, late embolization, erosion, and residual shunting.

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Device,equipment
Interventions/Control_1 Transcatheter closure of secundum atrial septal defect using Cocoon Septal Occluder (Vascular Innovation, Thailand)
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
4 years-old <
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patients with atrial septal defect more than 4 year old with
1, echocardiographic evidence of right ventricular volume overload.
2, significant left to right shunt
3,maximum diameter of ASD less than 40 mm with adequate rims.
Key exclusion criteria Aanomalous pulmonary venous connection,
Associated complex cardiac anomaly,
Eisenmenger syndrome,
Impaired left ventricular systolic function, and
Inadequate (<4mm) inferior vena cava (IVC) rim
Target sample size 320

Research contact person
Name of lead principal investigator
1st name Santosh
Middle name Kumar
Last name Sinha
Organization LPS Institute of Cardiology
Division name Department of Cardiology
Zip code 208002
Address D 17, Medical College Campus, GSVM, Swaroop Nagar
TEL 00917042132737
Email fionasan@rediffmail.com

Public contact
Name of contact person
1st name Najeeb
Middle name Ullah
Last name Sofi
Organization LPS institute of Cardiology
Division name Department of Cardiology
Zip code 208002
Address D 17, Medical College Campus, GSVM, Swaroop Nagar
TEL 0091-7042132737
Homepage URL
Email sofinajeeb@gmail.com

Sponsor
Institute LPS Institute of Cardiology
Department of Cardiology
Institute
Department

Funding Source
Organization LPS Institute of Cardiology
Department of Cardiology
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Institutional Ethical Committee, LPS institute of Cardiology
Address GT Road, Swaroop Nagar, Kanpur, UP, India 208002
Tel 0091-7042132737
Email sofinajeeb@gmail.com

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions LPS Institute of Cardiology

Other administrative information
Date of disclosure of the study information
2022 Year 05 Month 29 Day

Related information
URL releasing protocol
Publication of results Published

Result
URL related to results and publications
Number of participants that the trial has enrolled 320
Results Efficacy 312(97.5%)
Safety 312(97.5%)
Mean Procedural time (mins) 23.5
Mean Fluoroscopy time (mins) 6.8
Periprocedural complications 27 (8.4%)
Cardiac death 0 (0%)
Device embolization 2 (0.6%)
Cardiac perforation 1 (0.3%)
Pericardial effusion 3 (0.9%)
Transient supraventricular arrhythmias 15 (4.6%)
Transient atrioventricular block 6 (1.8%)
Local site hematoma 0 (0%)
Stroke 0 (0%)
Transient headache 8 (2.5%)

Closure rate 312 (100%)
Late embolization 0 (0%)
Erosion 0(0%)
Residual shunting 2 (0.6%)
Results date posted
2022 Year 05 Month 29 Day
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics Sex (Female/Male) 238(74%)/82(26%)
Age (years) 14.6 (6-29)

Clinical Indications
a. Right ventricular overload 320(100%)
b. Failure to thrive 81(25.3%)
c. Recurrent respiratory tract infection 73(22.8%)
d. Exrecise intolerance 57(17.%)
e. Pulmonary hypertension 13(4.1%)
f. Palpitation 9(2.8%)

Rhythm
a. Sinus rhythm 313(97.8%)
b. Atrial fibrillation (AFib) 5(1.5%)

Deficient rims (<5mm) 52(16.2%)
a. Posterior 14(4.3%)
b. Aortic 33(10.3%)
c. Superior 5(1.2%)
d. Inferior 0(0)
Absent aortic rim 11(3.4%)

Weight (kg) 30.2 (10-53)

Pulmonary vs. systemic flow (Qp/Qs) 2.6(1.4-3.6)

Associated disease 7(2.1%)
a. Rheumatic mitral stenosis 2(0.6%)
b. Patent ductus arteriosus (PDA) 3(0.9)
c. Ventricular septal defect (VSD) 2(0.6%)
Normal Situs solitus 317(99%)
Situs inversus 3(1%)

Follow up duration (months) 50.92 (12.5-89)
Hospital stay (hours) 29.4
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2012 Year 08 Month 03 Day
Date of IRB
2012 Year 09 Month 06 Day
Anticipated trial start date
2012 Year 11 Month 01 Day
Last follow-up date
2021 Year 09 Month 13 Day
Date of closure to data entry
2021 Year 09 Month 13 Day
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2022 Year 05 Month 29 Day
Last modified on
2022 Year 06 Month 09 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054582

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.